Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cytokinetics' stock rocketed Wednesday, after the cardiovascular-biopharmaceutical company announced positive results from a Phase 3 trial of aficamten, a...
By Will Feuer AlloVir, a clinical-stage cell-therapy company, said it has halted three of its late-stage clinical trials following recommendations from...
By Adria Calatayud Sanofi said it would end a clinical-development program for its tusamitamab ravtansine drug candidate after a late-stage trial in...
By Denny Jacob Immunovant shares rose 9.6% to $39.64 following positive data from a trial on its batoclimab treatment for Graves' disease, an immune system...
French pharmaceuticals giant Sanofi on Thursday said it would be halting development of a promising cancer treatment after the cutting-edge candidate failed...